Q4 2020 Redhill Biopharma Ltd Earnings Call Transcript
Good day, and welcome to the RedHill Biopharma Fourth Quarter and Full Year 2020 Financial Results Conference Call. (Operator Instructions)
At this time, I would like to introduce to the conference call RedHill's CEO: Dror Ben-Asher; Micha Ben-Chorin, RedHill's Chief Financial Officer; Rick Scruggs, RedHill's Chief Commercial Officer; Gilead Raday, RedHill's Chief Operating Officer; Guy Goldberg, RedHill's Chief Business Officer; Adi Frish, Chief Corporate and Business Development Officer; and Rob Jackson, RedHill's Senior Vice President, Sales and Marketing.
Before we begin, we will read now from RedHill's safe harbor statement. Please go ahead.
Thank you, Priscilla. This conference call may contain projections or other forward-looking statements regarding future events or the future performance of RedHill, including statements with respect to the business promotion and other efforts related to RedHill's commercialization activities and the initiation, timing, progress and results of RedHill's research, manufacturing, preclinical
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |